These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8015418)

  • 1. Complement activation by Pseudomonas aeruginosa biofilms.
    Jensen ET; Kharazmi A; Garred P; Kronborg G; Fomsgaard A; Mollnes TE; Høiby N
    Microb Pathog; 1993 Nov; 15(5):377-88. PubMed ID: 8015418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some bacterial parameters influencing the neutrophil oxidative burst response to Pseudomonas aeruginosa biofilms.
    Jensen ET; Kharazmi A; Høiby N; Costerton JW
    APMIS; 1992 Aug; 100(8):727-33. PubMed ID: 1325804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients.
    Bjarnsholt T; Jensen PØ; Fiandaca MJ; Pedersen J; Hansen CR; Andersen CB; Pressler T; Givskov M; Høiby N
    Pediatr Pulmonol; 2009 Jun; 44(6):547-58. PubMed ID: 19418571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity.
    Fick RB; Robbins RA; Squier SU; Schoderbek WE; Russ WD
    Pediatr Res; 1986 Dec; 20(12):1258-68. PubMed ID: 3540828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
    J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bovine innate immune response during experimentally-induced Pseudomonas aeruginosa mastitis.
    Bannerman DD; Chockalingam A; Paape MJ; Hope JC
    Vet Immunol Immunopathol; 2005 Sep; 107(3-4):201-15. PubMed ID: 15970335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated complement in the sputum from patients with cystic fibrosis.
    Schiøtz PO; Sørensen H; Høiby M
    Acta Pathol Microbiol Scand C; 1979 Feb; 87C(1):1-5. PubMed ID: 433601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. II. Complement activating property of the lipopolysaccharide portion and the inhibition by polymyxin B.
    Inada K
    Jpn J Exp Med; 1980 Apr; 50(2):107-15. PubMed ID: 6256561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-Pseudomonas aeruginosa antibodies, circulating immune complexes, and anticytoplasm antibodies of neutrophils in patients with cystic fibrosis with and without Pseudomonas aeruginosa colonization].
    Chiappini E; Taccetti G; Campana S; Turchini S; Marianelli L
    Pediatr Med Chir; 2001; 23(1):27-30. PubMed ID: 11486418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interspecies biofilms of Pseudomonas aeruginosa and Burkholderia cepacia.
    Tomlin KL; Coll OP; Ceri H
    Can J Microbiol; 2001 Oct; 47(10):949-54. PubMed ID: 11718549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the complement system and leukocyte recruitment by Tityus serrulatus scorpion venom.
    Bertazzi DT; de Assis-Pandochi AI; Talhaferro VL; Caleiro Seixas Azzolini AE; Pereira Crott LS; Arantes EC
    Int Immunopharmacol; 2005 Jun; 5(6):1077-84. PubMed ID: 15829423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.
    Hassett DJ; Sutton MD; Schurr MJ; Herr AB; Caldwell CC; Matu JO
    Trends Microbiol; 2009 Mar; 17(3):130-8. PubMed ID: 19231190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biofilm-forming Pseudomonas aeruginosa bacteria undergo lipopolysaccharide structural modifications and induce enhanced inflammatory cytokine response in human monocytes.
    Ciornei CD; Novikov A; Beloin C; Fitting C; Caroff M; Ghigo JM; Cavaillon JM; Adib-Conquy M
    Innate Immun; 2010 Oct; 16(5):288-301. PubMed ID: 19710099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Pseudomonas challenge in cystic fibrosis mice causes prolonged nuclear factor-kappa B activation, cytokine secretion, and persistent lung inflammation.
    Saadane A; Soltys J; Berger M
    J Allergy Clin Immunol; 2006 May; 117(5):1163-9. PubMed ID: 16675347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
    Tré-Hardy M; Vanderbist F; Traore H; Devleeschouwer MJ
    Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk assessment of Pseudomonas aeruginosa in water.
    Mena KD; Gerba CP
    Rev Environ Contam Toxicol; 2009; 201():71-115. PubMed ID: 19484589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaerobic culture conditions favor biofilm-like phenotypes in Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
    O'May CY; Reid DW; Kirov SM
    FEMS Immunol Med Microbiol; 2006 Dec; 48(3):373-80. PubMed ID: 17052266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression characteristics of a cystic fibrosis epidemic strain of Pseudomonas aeruginosa during biofilm and planktonic growth.
    Manos J; Arthur J; Rose B; Bell S; Tingpej P; Hu H; Webb J; Kjelleberg S; Gorrell MD; Bye P; Harbour C
    FEMS Microbiol Lett; 2009 Mar; 292(1):107-14. PubMed ID: 19222585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How much do Pseudomonas biofilms contribute to symptoms of pulmonary exacerbation in cystic fibrosis?
    VanDevanter DR; Van Dalfsen JM
    Pediatr Pulmonol; 2005 Jun; 39(6):504-6. PubMed ID: 15830388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.